COMMUNIQUÉS West-GlobeNewswire

Xbrane invites to a webinar about the recently entered co-development agreement with STADA

16/07/2018 - 12:25

Press release 2018-07-16 Xbrane Biopharma AB ("Xbrane") invites investors, analyst and media to a webinar where the recently disclosed co-development agreement with STADA Arzneimittel AG ("STADA") for Xlucane will be [...]

iKang Announces Extraordinary General Meeting of Shareholders

16/07/2018 - 12:13

BEIJING, July 16, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq:KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]

Cerecor Announces Expansion of Leadership Team

16/07/2018 - 12:00

New Leadership Supports Company Evolution into Innovative Specialty Pharmaceutical Company BALTIMORE, July 16, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ:CERC), today announced executive management changes that [...]

PotNetwork Holdings, Inc. Files Form 10 to Become Fully Reporting SEC Company

16/07/2018 - 12:00

FT. LAUDERDALE, Fla., July 16, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE—PotNetwork Holdings, Inc. (OTC Pink:POTN) announced today that the Company has filed a registration statement on Form 10 with the Securities and [...]

Sernova Announces $2,000,000 First Closing of Private Placement

16/07/2018 - 12:00

Due to Oversubscription , Offering Increased to $2,700,000 THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. LONDON, Ontario, July 16, 2018 ( [...]

Transactions under Novozymes’ stock buyback program

16/07/2018 - 11:49

Please read the full announcement in the attached PDF Attachment 2018_43_Stock_Buybackprogram_EN

Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration

16/07/2018 - 11:30

Sunnyvale, July 16, 2018 (GLOBE NEWSWIRE) -- July 16, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the [...]

Genetic Technologies Limited Announces Expansion of Genetic Risk Assessment Tests and October Launch of New Breast Cancer and Colorectal Cancer Tests

16/07/2018 - 11:30

MELBOURNE, Australia, July 16, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic [...]

SuperSonic Imagine Granted FDA Clearance and CE Marking for Disruptive New Aixplorer MACH® 30 Ultrasound System

16/07/2018 - 11:00

AIX-EN-PROVENCE, France, July 16, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specialised in ultrasound medical imaging, today announces it has received 510(k) clearance from the [...]

Enzymatica AB: Court ruling put restrictions on marketing of Enzymatica's cold spray in Germany

16/07/2018 - 08:31

Press release July 16, 2018 Court ruling put restrictions on marketing of Enzymatica's cold spray in Germany A decision in the regional court of Frankfurt has put restrictions on the marketing of the mouth spray [...]

Bio-on successfully completed the first test phase for the special bioplastic production facility inaugurated on 20 June.

16/07/2018 - 08:28

All tests on machines and software are positive and on schedule. The company confirms the full production regime by autumn. In 2018 about 150 tons of micro powders in special PHAs bioplastic will be produced and [...]

Shire plc : Rule 2.9 Announcement

16/07/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 16 July 2018 Shire [...]

Reva Expands Commercial Access to Fantom With New Distribution Partnership in Italy

16/07/2018 - 00:59

First Commercial Implant of the Fantom Bioresorbable Scaffold in Italy Successfully Completed SAN DIEGO, July 15, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in [...]

Akers Biosciences Announces Q1 2018 Earnings

14/07/2018 - 01:12

THOROFARE, N.J, July 13, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, reports its financial results [...]

Akers Biosciences Files Restated Previously Issued Financial Statements for 2017

14/07/2018 - 00:24

THOROFARE, N.J, July 13, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers”, “Akers Bio” or the "Company"), a developer of rapid health information technologies, has today filed [...]

PotNetwork Holdings, Inc. Files Form 10 to Become Fully Reporting SEC Company

14/07/2018 - 00:21

FT. LUADERDALE, Fla., July 13, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- PotNetwork Holdings, Inc. (OTC Pink:POTN) announced today that the Company has filed a registration statement on Form 10 with the Securities and [...]

Scythian Biosciences Announces Positive Pre-Clinical Data on the Safety and Efficacy of Cannabis Derived Combination Therapy for Mild to Moderate Traumatic Brain Injury

13/07/2018 - 23:05

TORONTO, July 13, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) and its partners at the University of Miami Miller School of [...]

Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program

13/07/2018 - 22:37

Company Release no. 13/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 13 July 2018 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis Pharmaceuticals [...]

Cellectar Announces 1-for-10 Reverse Stock Split

13/07/2018 - 22:05

MADISON, Wis., July 13, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments [...]